The elevated levels of NMNAT2 in ovarian cancer cells have been shown to decrease the accumulation of toxic proteins through the NMNAT2-NAD+-PARP16 pathway, which then supports cancer cell proliferation (Figure 3A) [38]. This evidence concerns the gene NMNAT2 and ovarian carcinoma.